Comparative analysis of somatostatin analog uptake between successfully irradiated and non-irradiated meningiomas

Campos Neto, Guilherme de Carvalho; Amaro Junior, Edson; Weltman, Eduardo; Malheiros, Suzana Maria Fleury; Ferrari, Bruna Letícia; Vitor, Taise; Barboza, Marycel Rosa Felisa Figols de; Bezerra, Rosemeire Pereira; Yamaga, Lilian Yuri Itaya; Wagner, Jairo; Baroni, Ronaldo Hueb.
Einstein (Säo Paulo) ; 20: eAO0104, 2022. tab, graf
Artículo en Inglés | LILACS-Express | ID: biblio-1404658

Documentos relacionados

  1. Comparative analysis of somatostatin analog uptake between successfully irradiated and non-irradiated meningiomas.
  2. The trends and significance of SSTR PET/CT added to MRI in follow-up imaging of low-grade meningioma treated with fractionated proton therapy.
  3. Meningioma WHO I with involvement of the optical structures-does proton therapy lead to changes in quality of life with regard to subjective visual performance?
  4. Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [<sup>18</sup>F]SiTATE.
  5. Pharmacokinetic analysis of [<sup>68</sup>Ga]Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2.
  6. Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
  7. Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
  8. Amide Proton Transfer Weighted MR Imaging for Predicting Meningioma Stiffness: A Feasibility Study.
  9. Principal component analysis of texture features for grading of meningioma: not effective from the peritumoral area but effective from the tumor area.
  10. Differences in the expression of SSTR1-5 in meningiomas and its therapeutic potential.